Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure

M Kosiborod, I Gause-Nilsson, J Xu… - Journal of diabetes and …, 2017 - Elsevier
Aim We investigated the efficacy and safety of dapagliflozin, a sodium–glucose
cotransporter 2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) and heart failure …
被引用次数：52 相关文章

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure

M Kosiborod, I Gause-Nilsson, J Xu… - Journal of diabetes …, 2017 - pubmed.ncbi.nlm.nih.gov
Aim We investigated the efficacy and safety of dapagliflozin, a sodium-glucose cotransporter
2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) and heart failure (HF). Methods …

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure.

M Kosiborod, I Gause-Nilsson, J Xu… - Journal of Diabetes …, 2017 - europepmc.org
Aim We investigated the efficacy and safety of dapagliflozin, a sodium-glucose cotransporter
2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) and heart failure (HF). Methods …